Targeting PLD1 in ApcMin/+ and colitis-associated CRC mice decreases the level of nuclear β-catenin but not membrane-associated β-catenin, which is detected both in the nontransformed areas of the intestines and in the normal areas of ApcMin/+ mice15. The gene discussed is PLD1; the disease is colorectal carcinoma.